Core Insights - Heart Hospital of New Mexico has successfully completed 200 ventricular ablation procedures using Catheter Precision's VIVO system, marking a significant milestone for both the hospital and the technology [1][3]. Company Overview - Catheter Precision, Inc. is a U.S.-based medical device company focused on developing advanced products for the cardiac electrophysiology market [5]. - The company aims to improve the treatment of cardiac arrhythmias through innovative technology and collaboration with healthcare professionals [5]. Product Details - The VIVO system (View Into Ventricular Onset) is a non-invasive 3D imaging tool that helps physicians identify the origin of ventricular arrhythmias before procedures, thereby enhancing workflow and reducing procedure time [4]. - VIVO has received marketing clearance from the U.S. FDA and holds the CE Mark, indicating its compliance with European health standards [4]. Hospital Context - Heart Hospital of New Mexico is part of the Lovelace Health system, which includes five hospitals and over 300 healthcare providers, and is dedicated exclusively to cardiovascular care [2].
Milestone Achievement for Hospital Using Catheter Precision’s VIVO System